Publication
Article
Author(s):
Click here to read the statement of need, learning objectives, instructions on how to obtain CME credit, faculty list and disclosures, and other information for this activity.
CME Reviews: Volume 31, No. 2
Release date: May 19, 2015
Expiration date: May 19, 2016
Media used: Internet-based
Estimated time to complete this CME activity: 1 hour
Statement of Need
Cardiovascular disease (CVD) is the leading cause of death in the United States. It is estimated that 83 million American adults have 1 or more forms of CVD. New agents, procedures, and interventions have improved patient outcomes, with decreased mortality and morbidity rates. However, as the population ages and younger adults develop comorbidities due to unhealthy lifestyles, the patient population at risk for cardiovascular events is increasing.
Care for patients with CVD has become increasingly complex, and community-based cardiologists often struggle to stay up-to-date with the volume of new data. The overall goals of this publication are to provide timely and pertinent original research articles that review current guidelines, practices, and new developments in the field of cardiovascular medicine. The publication also emphasizes preventing CVD by modifying risk factors through such strategies as healthy eating, regular exercise, and avoidance of smoking.
Target Audience
The target audience for this activity is cardiologists.
CME Learning Objectives
At the conclusion of this activity, participants should be able to:
1. Gain insight into the efficacy of the coronary sinus reducer in patients with refractory angina.
2. Compare the role of fractional flow reserve by coronary angiography versus atherosclerotic plaque characteristics by coronary CT angiography for prognosis.
Financial Disclosure
As a sponsor accredited by the ACCME, it is the policy of Physicians’ Education Resource®, LLC (PER®), to require the disclosure of anyone who is in a position to control the content of an educational activity. All relevant financial relationships with any commercial interests and/or manufacturers must be disclosed to participants prior to the beginning of each CME activity. PER has identified and resolved all conflicts of interest prior to the release of this activity.
Off-Label Disclosure and Disclaimer
This CME activity may or may not discuss investigational, unapproved, or off-label use of drugs. Participants are advised to consult prescribing information for any products discussed. The information provided in this CME activity is for continuing medical education purposes only and is not meant to substitute for the independent medical judgment of a physician relative to diagnostic and treatment options for a specific patient’s medical condition.
Sources of Funding
No educational grants from commercial interests were received.
Instructions for Receiving Credit
In order to receive a CME certificate for this activity, participants must read each review and activity in its entirety.
In order to receive a CME certificate, participants should:
Accreditation and Designation of Credit
Physicians’ Education Resource®, LLC, is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians.
Physicians’ Education Resource®, LLC, designates this enduring material for a maximum of 1.0 AMA PRA Category 1 Credit™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
Faculty
Editor in Chief:
Debabrata Mukherjee, MD, MS, FACC
Chief, Cardiovascular Medicine
Clinical and Research Fellow
Vice Chairman, Department of Internal Medicine
Texas Tech University Health Sciences Center
El Paso, TX
Alison L. Bailey, MD
Assistant Professor of Medicine
Director, Cardiac Rehabilitation
Associate Director, Cardiovascular Fellowship Program
Gill Heart Institute
University of Kentucky
Lexington, KY
Leslie Campbell, MD, FACC
Director, Advanced Heart Failure and Transplant
Barry S. Levin, M.D. Department of Transplantation
California Pacific Medical Center
San Francisco, CA
Saurav Chatterjee, MD
Fellow, Cardiovascular Diseases
Division of Cardiology
St. Luke’s-Roosevelt Hospital Center
New York, NY
Nezar Falluji, MD, MPH, FACC, FSCAI
Interventional Cardiologist
Executive Director, Kentucky One Health Cardiovascular Service Line
Co-director, Trans-catheter Valve Program
Saint Joseph Heart and Vascular Institute
Lexington, KY
Maryna Popp Switzer, DO
Texas Tech University Health Sciences Center
El Paso, TX
The following individuals have no relevant financial relationships with commercial interests to disclose:
Authors: Sucheta Gosavi, MD; Niki Katsiki, MsC, PhD, MD, FRsPh; Harold L. Lazar, MD; Glenn N. Levine, MD, FACC, FAHA; Rabab Mohsin, MD; Karla Quevedo, MD; Khaled M. Ziada, MD, FACC, FSCAI
Planner, reviewer, and editor in chief: Debabrata Mukherjee, MD, MS, FACC
Planner, reviewer, and editor-in-chief: Debabrata Mukherjee, MD, MS, FACC
PER® planners and staff: Ann C. Lichti, CHCP; Emily Valko Lohrmann; and Kerry Clayton
Cardiology Review staff: Todd Kunkler; Jackie Syrop
Provider Contact Information:
Physicians’ Education Resource®, LLC
666 Plainsboro Road, Suite 356
Plainsboro, NJ 08536
Toll Free: 888-949-0045
Local: 609-378-3701
Fax: 609-257-0705